ERBB2 and breast cancer: Indeed, from a molecular perspective, BC is composed of at least four main so-called intrinsic subtypes, namely luminal A, luminal B, HER2-enriched and basal-like (BL), with different clinical behavior, prognosis, and response to different treatments [10].